Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
---|
11/05/1996 | US5571840 Method for treating central nervous system ischemia |
10/30/1996 | CN1134669A Use of thiazolidinediones to prevent or delay onset of NIDDM |
10/29/1996 | US5569654 Benzodiazepinones |
10/29/1996 | CA2073873C Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders |
10/24/1996 | WO1996032938A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
10/24/1996 | CA2218391A1 Alpha 1a adrenergic receptor antagonists |
10/23/1996 | EP0738154A1 N-terminus modified analogs of lhrh |
10/23/1996 | EP0593491B1 Luteinizing hormone releasing hormone antagonist peptides |
10/23/1996 | CN1134155A Androstenones |
10/22/1996 | US5567831 Non-steroidal sulfatase inhibitor compounds and their method of use |
10/22/1996 | US5567728 Receptor ligands |
10/22/1996 | US5567712 Naphthyl compounds, intermediates, compositions and methods |
10/22/1996 | CA1338667C Anti-androgen compounds |
10/17/1996 | WO1996032152A1 Pulmonary administration of dry powder alpha 1-antitrypsin |
10/17/1996 | WO1996032149A1 Pulmonary delivery of aerosolized medicaments |
10/17/1996 | CA2218208A1 Pulmonary administration of dry powder alpha 1-antitrypsin |
10/16/1996 | CN1033033C 19, 11 beta-bridged steroids with progestone anti-activity preparation method |
10/15/1996 | US5565464 Compounds having angiotensine II antagonistic activity |
10/09/1996 | EP0736039A1 Compounds with growth hormone releasing properties |
10/09/1996 | EP0736038A1 Compounds with growth hormone releasing properties |
10/09/1996 | EP0735863A1 Accelerated release composition containing bromocriptine |
10/09/1996 | CN1133047A Therapeutic peptide derivatives |
10/09/1996 | CN1032951C Tortoise and soft-shelled turtle composition and its prep. |
10/08/1996 | US5563278 Angiotensin II antagonists |
10/08/1996 | US5563044 Process for the enzymatic preparation of GRF(1-44)NH2 |
10/08/1996 | CA2051697C Heterocyclic amines having central nervous system activity |
10/03/1996 | WO1996030050A1 Gene therapy by secretory gland expression |
10/03/1996 | WO1996030031A1 Isolated stromal cells and methods of using the same |
10/03/1996 | CA2216149A1 Gene therapy by secretory gland expression |
10/03/1996 | CA2215143A1 Isolated stromal cells and methods of using the same |
10/02/1996 | EP0734396A1 ANALOGUES OF hGH-RH (1-29)NH 2? HAVING ANTAGONISTIC ACTIVITY |
10/02/1996 | CN1132205A Novel pharmaceutical product |
10/01/1996 | US5561123 Antitumor agents, anticarcinogenic agent |
09/26/1996 | WO1996022760A3 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon |
09/25/1996 | EP0733109A1 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
09/25/1996 | EP0733071A1 Antagonists to chaperonin 10 |
09/25/1996 | EP0733048A1 Heterocyclic biphenylylamides useful as 5ht1d antagonists |
09/25/1996 | EP0732934A1 Long-acting injection suspensions and a process for their preparation |
09/25/1996 | EP0732875A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
09/25/1996 | CN1131907A Skin patches and methods for providing testosterone |
09/24/1996 | US5559123 Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same |
09/19/1996 | WO1996028548A1 Receptor activation by gas6 |
09/19/1996 | WO1996028146A1 Novel naphthyl pharmaceutical compounds |
09/19/1996 | CA2214416A1 Novel naphthyl pharmaceutical compounds |
09/18/1996 | EP0732101A1 Use of L-deprenyl for retarding age dependent deterioration of the immune system function in mammals |
09/18/1996 | EP0731811A1 Chaperonin 10 |
09/18/1996 | EP0731795A1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation |
09/18/1996 | CN1131391A Use of thiazolidinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus |
09/18/1996 | CN1131154A 8-oxy-5,8-dihydro-6H-dibenzo|a,g¨quinolizine-13-propionic acid derivant, its preparation method and medicinal use thereof |
09/17/1996 | US5556845 11-β substituted-19-nor steroids |
09/17/1996 | US5556763 Patterns of transcription factors and lymphocytes |
09/11/1996 | EP0731093A1 Naphthyl pharmaceutical compounds |
09/11/1996 | EP0730657A1 Composition for the in vivo production of therapeutic products |
09/11/1996 | EP0730651A1 Surface loop structural analogues of fibroblast growth factors |
09/11/1996 | EP0730470A1 Improved interferon polymer conjugates |
09/04/1996 | EP0729956A1 Benzothiophene compounds, intermediates, compositions, and methods |
09/04/1996 | EP0729951A1 Naphthyl compounds, intermediates, compositions, and methods |
09/04/1996 | CN1130085A Hyperthyroidism plaster and its preparing method |
09/03/1996 | US5552520 Such as somatostatin analogs or bombesin analogs |
09/03/1996 | US5552415 Cognition activators |
09/03/1996 | US5552412 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis |
09/03/1996 | CA2033113C Estrogen-containing gel preparation |
08/29/1996 | CA2566828A1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
08/29/1996 | CA2170337A1 Naphthyl compounds, intermediates, compositions, and methods |
08/28/1996 | EP0728194A1 $i(IN SITU) MODIFICATION AND MANIPULATION OF STEM CELLS OF THE CENTRAL NERVOUS SYSTEM |
08/28/1996 | EP0728143A1 Oncoprotein protein kinase |
08/28/1996 | EP0536226B1 The combination of growth hormone and insulin-like growth factor-i enhances growth |
08/27/1996 | US5550212 Analogues of hGH-RH(1-29)NH2 having antagonistic activity |
08/27/1996 | US5550150 Using a benzothiophene compound |
08/27/1996 | US5550110 Pentapeptide and hexapeptide analogs of endothelin-1 |
08/27/1996 | US5550107 Anticarcinogenic agents and antiestrogens |
08/22/1996 | WO1996025498A2 Mpl ligand analogs |
08/21/1996 | EP0726908A1 Oncoprotein protein kinase |
08/21/1996 | EP0726901A1 Benzo-fused macrocycles promote release of growth hormone |
08/21/1996 | EP0726771A1 Desferrioxamine oral delivery system |
08/21/1996 | EP0584186B1 Receptor ligands |
08/21/1996 | EP0517820B1 Use of 3-guanidinopropionic acid in the manufacture of a medicament for the treatment and prevention of excess adiposity |
08/08/1996 | WO1996023501A1 Methods of decreasing serum calcium levels |
08/08/1996 | CA2211530A1 Methods of decreasing serum calcium levels |
08/07/1996 | EP0725074A2 Compounds suitable for use as intermediates in the preparation of Androst-3,5-dien-3-carboxy derivatives |
08/07/1996 | EP0724592A1 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors |
08/07/1996 | CN1128271A Preparation of stable zinc insulin analog crystals |
08/06/1996 | US5543150 Method of progesterone delivery and affect thereof |
08/06/1996 | CA2026783C Use of il-7 in providing medications for stimulation of platelet production |
08/01/1996 | WO1996022760A2 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon |
08/01/1996 | CA2210737A1 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon |
07/31/1996 | EP0723780A2 2-Phenyl-3-azoylbenzothiopenes for decreasing serum calcium levels |
07/31/1996 | EP0723453A1 Method of treating reproductive disorders |
07/31/1996 | CN1128031A 15,15-dialkyl-substituted derivatives of estradiol |
07/31/1996 | CN1127753A New imidazolidines substituted by a heterocycle, their preparation process and intermediates, their use as medicaments NAD the pharmaceutical compositions containing them |
07/30/1996 | US5541228 Melatonergic agents |
07/24/1996 | EP0722324A1 Pharmaceutical composition for immunoenhancement therapy |
07/24/1996 | CN1127253A Synthesis of 3-(4-(2-aminoethoxy)-benzoyl)-2-aryl-6-hydroxybenzo(b) thiophenes 08/01/31 |
07/18/1996 | WO1996021656A1 Estrogen agonists/antagonists |
07/18/1996 | WO1996021441A1 Methods of inhibiting growth hormone effects |
07/18/1996 | CA2209891A1 Methods of inhibiting growth hormone effects |
07/16/1996 | US5536812 Calcitonin analogue and use thereof |
07/16/1996 | US5536714 Steroid derivatives for the treatment of prostatic hypertrophy their preparation and uses |
07/11/1996 | WO1996020936A1 Novel thiazolidin-4-one derivatives |
07/11/1996 | CA2184174A1 Novel thiazolidin-4-one derivatives |